Pharmanutra Logo

Pharmanutra

PHN | XMIL

Overview

Corporate Details

ISIN(s):
IT0005274094
LEI:
815600F8217BC7733697
Country:
Italy
Address:
VIA CAMPODAVELA, 1, 56122 PISA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmaNutra S.p.A., established in 2003, is an Italian company specializing in the research, development, and marketing of nutraceutical products, food supplements, and medical devices. The company focuses on creating innovative and scientifically-backed solutions, particularly for nutritional deficiencies in minerals and vitamins, as well as for muscle and joint health. PharmaNutra manages the entire production cycle, from proprietary raw materials to the finished product, ensuring high standards of efficacy and safety. The group also develops and sells pharmaceuticals, distinguishing itself through a strong emphasis on scientific research and innovation.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Pharmanutra. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 18:05
Regulatory News Service
PR PHARMANUTRA SPA - Sidevit B12 sales
English 465.8 KB
2025-08-04 18:04
Earnings Release
CS PHARMANUTRA SPA - Vendite Sidevit B12
Italian 259.1 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Lancio ApportAL Boost
Italian 189.4 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Launch of ApportAL Boost
English 241.0 KB
2025-05-27 10:47
Investor Presentation
MIDCAP Road Show - Paris
English 3.4 MB
2025-05-15 15:26
Registration Form
Statuto sociale aggiornato
Italian 295.1 KB
2025-05-15 15:25
Pre-Annual General Meeting Information
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
Italian 9.4 MB
2025-05-15 15:23
Post-Annual General Meeting Information
Pharmanutra: Avviso deposito verbale Assemblea e Statuto aggiornato_Filing of m…
Italian 172.3 KB
2025-05-14 11:46
Quarterly Report
Interim Management report as at March 31st, 2025
English 1.7 MB
2025-05-14 11:45
Management Discussion and Analysis
Resoconto Intermedio di gestione al 31 Marzo 2025
Italian 1.4 MB
2025-05-14 11:44
Report Publication Announcement
Avviso deposito Rendiconto Intermedio di gestione al 31 marzo 2025 || Notice of…
Italian 177.0 KB
2025-05-12 17:30
Earnings Release
Pharmanutra: CdA approva il Resoconto intermedio di gestione al 31 marzo 2025
Italian 282.7 KB
2025-05-12 17:30
Quarterly Report
Pharmanutra: BoD approves the Intermin management report as of March 31, 2025
English 349.0 KB
2025-05-06 17:02
Director's Dealing
Allegato 3F - Aprile 2025
Italian 92.0 KB
2025-04-22 16:41
Post-Annual General Meeting Information
PHARMANUTRA: Voting Summary Report
English 341.1 KB

Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmanutra via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioLineRx Ltd. Logo
Biopharma firm developing and commercializing therapies for cancer and rare diseases.
Israel BLRX
BioMaxima S.A. Logo
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
Poland BMX
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech producer of APIs like Penicillin for human & vet use, offering contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden BIOVIC